[Is lymphadenectomy in stage I of non-seminomatous testicular cancer still justified?].
Testicular cancer is the tumour of the male genital tract which is most easily and successfully treated today. This very circumstance dictates that for ethical reasons we are more bound than ever to prevent unnecessary diagnostic and therapeutic procedures in these young patients. They should receive only the maximum necessary and not the maximum possible therapy. The difference between these two critical concepts determines the extent of treatment morbidity. Retroperitoneal lymphadenectomy (RLA) is only a diagnostic procedure in approximately 85% of cases. This is the reason for critically reviewing the necessity of this investigation in early non-seminomatous cancer of the testes. The prognostic impact of vascular invasion by the primary tumour is demonstrated in a retrospective study of 86 pathohistological specimens of germ cell tumours. We suggest the inclusion of vascular invasion basically as criterion for any prospective "wait and see" protocol in early non-seminomatous germ cell tumours.
D003131:Combined Modality Therapy; D004407:Dysgerminoma / Q000601:surgery; D006801:Humans; D008197:Lymph Node Excision; D008207:Lymphatic Metastasis; D008297:Male; D009367:Neoplasm Staging; D009360:Neoplastic Cells, Circulating; D009919:Orchiectomy; D013736:Testicular Neoplasms / Q000473:pathology / Q000601:surgery*
Ist die Lymphadenektomie im Stadium I des nichtseminomatösen Hodentumors noch gerechtfertigt?